"Official medicines" is the best online drugstore.World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system. The meds you need, reliable and hassle free! Top products of top brands.The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe! |
| (low-SAHR-tan poe-TASS-ee-uhm) |
| Cozaar |
| Tablets: 25 mg |
| Tablets: 50 mg |
| Tablets: 100 mg |
| Class: Antihypertensive, Angiotensin II antagonist |
Action Antagonizes the effect of angiotension II (vasoconstriction and aldosterone secretion) by blocking the angiotensin II receptor (AT1 receptor) in vascular smooth muscle and the adrenal gland, producing decreased BP.
Treatment of hypertension; nephropathy in type 2 diabetic patients.
Contraindications Standard considerations.
Hypertension
Adults: PO Initial dose: 50 mg once/day; 25 mg once/day if volume depleted or history of hepatic impairment. Maintenance: 25 to 100 mg/day.
Nephropathy in Type 2 Diabetes
Adults: PO Initial dose: 50 mg once daily; the dose may be increased to 100 mg once daily based on BP response.
Lithium
Plasma concentrations may be increased by losartan, resulting in an increase in the pharmacologic and adverse effects of lithium.
Lab Test Interferences None well documented.
CNS: Dizziness; insomnia. EENT: Nasal congestion. GI: Diarrhea; dyspepsia. RESPIRATORY: Cough; sinusitis. OTHER: Muscle cramps; myalgia; back pain; leg pain.
Pregnancy: Category D (second and third trimester); Category C (first trimester). Can cause injury or death to fetus if used during second or third trimester. Lactation: Undetermined. Children: Safety and efficacy in children younger than 18 yr not established. Renal function impairment: Use caution in treating patients whose renal function may depend on the activity of the renin-angiotension-aldosterone system (eg, patients with severe CHF). Hepatic function impairment: Losartan total plasma clearance is lower (50%) and total bioavailability is higher (2-fold) in patients with hepatic insufficiency as compared with healthy subjects. A lower initial dose is recommended for patients with a history of hepatic impairment. Hypotension/Volume-depleted patients: Symptomatic hypotension may occur after initiation of losartan in patients who are intravascularly volume depleted (eg, those treated with diuretics). Correct these conditions prior to administration of losartan or use a lower starting dose. African-Americans: Losartan may not be as effective in African-Americans.
| PATIENT CARE CONSIDERATIONS |
|
|
||||
Popularity: 3% [?]
RSS feed for comments on this post · TrackBack URI
Leave a reply